H.R. 5382 · 116th Congress

To create a mechanism whereby insulin manufacturers may sell directly to consumers at current net prices.

Stage
In committee
Sponsor
Jeff Fortenberry
Introduced
2019-12-10
Latest action
2019-12-11 · Referred to the Subcommittee on Health.

Action history

  1. 2019-12-11Referred to the Subcommittee on Health.
  2. 2019-12-10Introduced in House
  3. 2019-12-10Referred to the House Committee on Energy and Commerce.